Abstract
To evaluate the prognostic impact of maximum standardized uptake value (SUVmax) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) undergoing pretreatment [F-18] fluoro-D-glucose-positron emission tomography/computed tomography (FDG PET/CT) imaging. Fifty-eight patients undergoing FDG PET/CT before radical treatment with definitive radiotherapy (±concomitant chemotherapy) or surgery+postoperative (chemo)radiation were analyzed. The effects of clinicopathological factors (age, gender, tumor location, stage, Karnofsky Performance Status (KPS), and treatment strategy) including primary tumor SUVmax and nodal SUVmax on overall survival (OS), disease-free survival (DFS), locoregional control (LRC), and distant metastasis-free survival (DMFS) were evaluated. Kaplan-Meier survival curves were generated and compared with the log-rank test. Median follow-up for the whole population was 31months (range 2.3-53.5). Two-year OS, LRC, DFS and DMFS, for the entire cohort were 62.1, 78.3, 55.2 and 67.2%, respectively. Median pretreatment SUVmax for the primary tumor and lymph nodes was 11.85 and 5.4, respectively. According to univariate analysis, patients with KPS<80% (p<0.001), AJCC stage IVa or IVb vs III (p=0.037) and patients undergoing radiotherapy vs surgery (p=0.042) were significantly associated with worse OS. Patients with KPS<80% (p=0.003) or age ≥65years (p=0.007) had worse LRC. The KPS<80% was the only factor associated with decreased DFS (p=0.001). SUVmax of the primary tumor or the lymph nodes were not associated with OS, DFS or LRC. The KPS<80% (p=0.002), tumor location (p=0.047) and AJCC stage (p=0.025) were associated with worse cancer-specific survival (CSS). According to Cox regression analysis, on multivariate analysis KPS<80% was the only independent parameter determining worse OS, DFS, CSS. Regarding LRC only patients with IK<80% (p=0.01) and ≥65years (p=0.01) remained statistically significant. Nodal SUVmax was the only factor associated with decreased DMFS. Patients with a nodal SUVmax>5.4 presented an increased risk for distant metastases (HR, 3.3; 95% CI 1.17-9.25; p=0.023). The pretreatment nodal SUVmax in patients with locally advanced HNSCC is prognostic for DMFS. However, according to our results primary tumor SUVmax and nodal SUVmax were not significantly related to OS, DFS or LRC. Patients presenting KPS<80% had worse OS, DFS, CSS and LRC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.